New Trial Studies Psilocybin Treatment for People with Alcohol Use Disorder
A randomized controlled trial examined the experiences of people with alcohol use disorder after being treated with psilocybin.
A recent trial, published in the journal Psychology of Addictive Behaviors, reported the effects of psilocybin-assisted psychotherapy in treating alcohol use disorder (AUD) (1). Thirteen participants answered interview questions before and after the treatment regarding coping strategies, cravings, and stress among other topics (1). The study is reportedly the first ever of its type (1).
“Participants reported that the psilocybin treatment helped them process emotions related to painful past events and helped promote states of self-compassion, self-awareness, and feelings of interconnectedness,” state the Results (1). According to the responses, the psilocybin helped participants experience new, more positive emotions such as a sense of belonging (1).
“Our findings suggest that psilocybin treatment prompted meaningful and enduring improvements in self-compassion and affect regulation,” read the Impact Statement, in part (1). “These psychological processes may help individuals with AUD cope with difficult emotions and stress and prevent relapse by encouraging adaptive coping responses.”
Reference
- Agin-Liebes, G.; Nielson, E. M.; Zingman, M.; Kim, K.; Haas, A.; Owens, L. T.; Rogers, U.; Bogenschutz, M. Reports of Self-Compassion and Affect Regulation in Psilocybin-Assisted Therapy for Alcohol Use Disorder: An Interpretive Phenomenological Analysis. Psychology of Addictive Behaviors 2023.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
